Molex
Corporate brand
UnclaimedA global manufacturer of electronic, electrical, and fiber-optic connectivity systems.
Last updated August 31, 2026
Overview
Molex is a United States-based manufacturer of electronic, electrical, and fiber-optic connectivity systems. Its portfolio includes connectors, cable assemblies, wire harnesses, antennas, sensors, switches, and other interconnection products used to transmit power, signals, data, and light. The company serves a broad range of markets, including automotive, data communications, telecommunications, consumer electronics, medical technology, industrial automation, appliances, aerospace, and transportation. The business was founded in 1938 by Frederick August Krehbiel. Its original products were not electronic components: Molex initially manufactured flowerpots and other molded plastic goods from an industrial byproduct material called Molex. It later produced items such as salt shakers before applying its plastics expertise to electrical connectors and components for appliance manufacturers, including General Electric. This transition established the foundation for the company’s subsequent focus on engineered interconnection systems. Molex became particularly associated with the Molex connector used in personal computers and other electronic equipment. Although the name is used broadly for several families of connectors, the company’s products are designed for specific electrical, mechanical, environmental, and manufacturing requirements rather than as a single universal component. Over time, Molex expanded from commodity-style connectors into higher-complexity systems, including high-speed data interconnects, automotive assemblies, industrial controls, medical devices, fiber-optic products, and three-dimensional molded electronic components. The company pursued international manufacturing and acquisition-led expansion. By the late 2000s, it operated a large global manufacturing footprint and supplied customers across multiple technology and industrial sectors. Its acquisition of Woodhead Industries in 2006 broadened its industrial connectivity and automation capabilities. In 2011, Molex expanded further into complex three-dimensional electronic components for medical applications, reflecting a move toward specialized, higher-value engineered solutions. Molex was acquired by Koch Industries in September 2013 in a transaction valued at approximately $7.2 billion. After the acquisition, Molex retained its name and Lisle headquarters and continued operating as a Koch subsidiary. Subsequent expansion included the 2016 acquisition of Phillips Medisize, a contract manufacturer and product-development specialist serving medical and pharmaceutical applications. Phillips Medisize added capabilities in drug delivery, portable medical devices, primary pharmaceutical packaging, diagnostics, and injection molding. Molex presents itself as an engineering and manufacturing partner rather than merely a connector vendor. Its business combines product design, materials and process engineering, tooling, automated production, testing, and supply-chain support. Current activities span traditional connectors as well as high-speed data systems, automotive electrification and connectivity, medical and pharmaceutical delivery platforms, industrial networking, and solutions for data-center infrastructure. The company remains privately held as a subsidiary of Koch Industries.
History
Molex began in 1938 under the leadership of Frederick August Krehbiel. The company’s first products were molded plastic goods, particularly flowerpots, made from an industrial byproduct material known as Molex. It also produced household items such as salt shakers. The business later used the same materials expertise to manufacture electrical connectors and related components for appliance manufacturers, including General Electric. This transition from molded consumer goods to engineered electrical components shaped the company’s long-term identity. As electronics and electrical systems became more complex, Molex expanded into connector design and production for industrial and consumer applications. Its connector products became widely associated with personal computers, where Molex-style power connectors were used across generations of computer hardware. The company’s broader portfolio also developed to include wire harnesses, cable assemblies, sensors, switches, antennas, and fiber-optic connectivity products. Molex internationalized its manufacturing and customer base over several decades. By the late 2000s, the company operated dozens of manufacturing plants worldwide and supplied customers in data communications, medical, industrial, automotive, appliance, and consumer-electronics markets. In 2006, it acquired Woodhead Industries, described as its largest acquisition at that time. Woodhead strengthened Molex’s position in industrial connectivity and automation-related applications. In 2005, Molex disclosed adjustments to previously reported financial results relating to the first quarter of fiscal 2005 and the six months ended December 31, 2004. A shareholder class action followed, alleging that the company and certain executives and directors had made materially false or misleading statements that inflated the market price. The litigation was settled in 2007 through a fund reported at $10.5 million plus interest. These events form part of the company’s documented corporate history but did not end its operations. Molex continued to move toward specialized engineering markets. In 2011, it began producing complex three-dimensional electronic components for medical applications. This reflected a broader strategy of combining materials, molding, electrical design, and manufacturing automation to address highly specified customer requirements. Koch Industries acquired Molex in September 2013 for approximately $7.2 billion. Koch stated that Molex would keep its established name and Lisle headquarters and operate as a subsidiary. The transaction changed Molex from a publicly traded company into a privately held Koch business, while preserving its operating identity. The company expanded its medical and pharmaceutical platform in November 2016 through the acquisition of Phillips Medisize. Phillips Medisize specialized in plastic injection molding, medical instruments, drug-delivery systems, portable and mobile medical devices, primary pharmaceutical packaging, and diagnostic products. Its integration added product-development and contract-manufacturing capabilities to Molex’s existing medical activities. Reference material also identifies later pharmaceutical and connectivity expansion, including the effective January 2025 acquisition of Vectura, a British inhalation drug-delivery specialist, and a reported October 2025 agreement to acquire Smiths Interconnect from Smiths Group. The latter transaction was described as valued at approximately £1.3 billion and completed in April 2026; these dates are retained as reported in the supplied reference material and should be independently verified for current-status publication. Today, Molex operates as a Koch Industries subsidiary and supplies connectivity and electronic systems globally. Its activities cover conventional and high-density connectors, high-speed data transmission, automotive systems, industrial equipment, fiber optics, medical devices, pharmaceutical delivery, and consumer electronics. The brand’s role is primarily that of a behind-the-scenes technology and manufacturing supplier whose components are incorporated into larger products and infrastructure.
- 2025
Vectura acquisition becomes effective
[1]Reference material identifies an effective January 2025 acquisition of Vectura, a British inhalation drug-delivery device maker.
- 2025
Smiths Interconnect acquisition is announced
[1]Molex reportedly agrees to acquire Smiths Interconnect, which makes connectivity products for rugged environments.
- 2016
Phillips Medisize is acquired
[1]The acquisition broadens Molex’s medical-device, pharmaceutical packaging, molding, diagnostics, and drug-delivery capabilities.
- 2013
Koch Industries acquires Molex
[1]Molex is acquired by Koch Industries for approximately $7.2 billion and becomes a privately held subsidiary.
- 2011
Medical three-dimensional electronic components are introduced
[1]Molex expands into complex three-dimensional electronic components for medical applications.
- 2007
Shareholder litigation is settled
[1]A settlement fund of $10.5 million plus interest is reached in the shareholder class action concerning earlier financial disclosures.
- 2006
Woodhead Industries is acquired
[1]Molex acquires Woodhead Industries, strengthening its industrial connectivity and automation-related activities.
- 2005
Financial results are adjusted
[1]Molex announces adjustments to results for the first fiscal quarter of fiscal 2005 and the six months ended December 31, 2004.
- 1938
Molex is established
[1]Frederick August Krehbiel establishes the company, initially manufacturing molded plastic goods such as flowerpots.
Products and positioning
A global, engineering-led connectivity and electronic systems supplier emphasizing reliability, application-specific design, manufacturing scale, and solutions for demanding industrial, automotive, data, consumer, and medical applications.
Connectivity
Electronic and electrical connectors
Molex produces a wide range of connectors for board-to-board, wire-to-board, wire-to-wire, power, signal, and appliance applications. Product families are engineered for different current levels, pitches, mating cycles, space constraints, environmental conditions, and assembly methods. The brand became especially recognizable through connector products used in personal computers, while its broader industrial portfolio serves automotive, telecommunications, consumer, and industrial equipment manufacturers.
Power and signal connectivity
Micro-Fit connector systems
Micro-Fit systems are compact connector families intended to provide relatively high power and signal density in space-constrained electronic assemblies. They are used in equipment where designers need a smaller interconnect while retaining mechanical retention and production flexibility. Applications can include industrial controls, consumer equipment, computing hardware, appliances, and other electronic systems.
Data communications
Fiber-optic and SFP interconnect systems
Molex supplies fiber-optic connectivity and small-form-factor-pluggable-related interconnect products for data communications and networking equipment. These offerings support the physical connection of high-speed optical and electrical signals inside network, telecommunications, and data-center infrastructure. The portfolio reflects Molex’s expansion beyond low-speed connectors into high-bandwidth systems requiring signal integrity, thermal management, and controlled manufacturing tolerances.
Automotive electronics
Automotive connectivity systems
Molex develops connectors, cable assemblies, antennas, sensors, and related systems for vehicles. Automotive products must withstand vibration, temperature changes, moisture, chemicals, and long service lives while supporting increasingly dense electronic architectures. The business serves applications associated with vehicle electronics, communications, power distribution, and emerging connected and electrified vehicle platforms.
Medical technology
Medical and pharmaceutical delivery systems
Through its own medical activities and the Phillips Medisize platform, Molex participates in the design and manufacture of medical devices, drug-delivery products, portable healthcare equipment, diagnostic products, and primary pharmaceutical packaging. These activities combine plastics processing, electronic integration, product development, tooling, and regulated manufacturing. The portfolio was expanded further through reference-reported activity involving inhalation drug-delivery specialist Vectura.
Interconnect assemblies
Wire harnesses and cable assemblies
Molex manufactures configured wire harnesses and cable assemblies that combine conductors, terminals, connectors, shielding, and protective elements into application-specific subassemblies. These products help customers simplify final assembly and control electrical performance, routing, serviceability, and reliability. They are used in vehicles, industrial machinery, communications equipment, medical devices, appliances, and consumer electronics.
Controversies
2005
Shareholder class action concerning financial disclosures
Following Molex’s announcement of adjustments to previously reported financial results, a class action was announced against the company and certain officers and directors. The complaint alleged that materially false or misleading statements had artificially inflated the company’s market price. A settlement fund of $10.5 million plus interest was reached in 2007.
Brand decisions
2025
Expand drug-delivery activities through VecturaM&ABackground
Molex’s medical strategy included adding specialized drug-delivery technology.
Action taken
Reference material identifies the acquisition of British inhalation drug-delivery specialist Vectura as effective in January 2025.
2025
Agree to acquire Smiths InterconnectM&ABackground
Molex sought to expand its connectivity offering for rugged and demanding environments.
Action taken
Reference material reports an agreement to acquire Smiths Interconnect from Smiths Group.
Aftermath
The supplied material reports completion in April 2026; this timing and completion status require independent verification.
Reported transaction value. £1.3 billion (Reported October 2025 agreement)
2016
Acquire Phillips MedisizeM&ABackground
Molex wanted to deepen its presence in medical devices, pharmaceutical packaging, drug delivery, and specialized plastics manufacturing.
Action taken
Molex acquired Phillips Medisize and incorporated its medical product-development and manufacturing capabilities into the group.
Aftermath
The acquisition broadened Molex’s medical and pharmaceutical platform, including molding, diagnostics, portable devices, and delivery systems.
2013
Accept Koch Industries acquisitionM&ABackground
Koch Industries proposed to purchase Molex as part of its expansion into engineered manufacturing businesses.
Action taken
Molex was acquired and became a privately held Koch Industries subsidiary, while retaining its name and Lisle headquarters.
Aftermath
Molex continued operating as a global connectivity supplier under Koch ownership.
Transaction value. $7.2 billion (2013 acquisition)
2011
Expand into three-dimensional medical electronic componentsProduct launchBackground
Molex sought to apply its molding and electronic-engineering expertise to more specialized medical applications.
Action taken
The company began producing complex three-dimensional electronic components for medical uses.
Aftermath
The move supported Molex’s broader shift toward specialized and higher-complexity medical technologies.
2006
Acquire Woodhead IndustriesM&ABackground
Molex was expanding its global connectivity portfolio and seeking greater depth in industrial applications.
Action taken
Molex acquired Woodhead Industries, described at the time as its largest acquisition.
Aftermath
The transaction strengthened Molex’s industrial connectivity and automation-related capabilities.
Recent events
- 2025
Molex expands into inhalation drug-delivery capabilities through Vectura[1]
M&A
Reference material identifies Vectura, a British maker of inhalation drug-delivery devices, as an acquisition effective in January 2025.
- 2025
Molex agrees to acquire Smiths Interconnect[1]
M&A
Reference material reports that Molex agreed to acquire Smiths Interconnect, a producer of connector devices for rugged environments, from Smiths Group in a transaction valued at approximately £1.3 billion.
- 2016
Molex acquires Phillips Medisize[1]
M&A
Molex acquired Wisconsin-based Phillips Medisize, expanding its medical-device and pharmaceutical manufacturing capabilities in areas including drug delivery, portable medical devices, packaging, diagnostics, and injection molding.
- 2013
Koch Industries agrees to acquire Molex[1]
M&A
Koch Industries announced an agreement to acquire Molex in a transaction valued at approximately $7.2 billion. Molex was expected to retain its name and Lisle headquarters while becoming a Koch subsidiary.
- 2005
Molex announces adjustments to previously reported financial results[1]
Other
Molex announced adjustments affecting its reported results for the first fiscal quarter of fiscal 2005 and the six months ended December 31, 2004.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/molex · Editorial policy · How profiles are compiled